Phase 3 N=140 Evaluation in the Treatment of Neuropathic Pain Post Breast Surgery
Breast Cancer Patient
Primary: Change in Neuropathic Pain Score at 2 Months (Numeric Rating Scale 0-10) — 4.1; 4.6 units on a scale
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 3 N=44 Brivaracetam to Reduce Neuropathic Pain in Chronic SCI: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
Spinal Cord Injuries · Neuropathic Pain
Primary: The International Spinal Cord Injury Pain Data Set (ISCIPBDS) (Version 2.0) - Change in Average Worst Neuropathic Pain Intensity — -0.5; -0.5 points
N/A N=22 Scrambler Trial for Pain in NMOSD
Neuromyelitis Optica
Primary: Acceptability as Assessed by the Number of Participants Responding Yes to a Question — 7; 5 Participants
N/A N=10 Effectiveness of rTMS on Pain and Quality of Life in Patients With Cancer Neuropathic Pain. Clinical Trial.
Neuropathic Pain
Primary: Effect of Change of 20 rTMS Sessions on Pain — 5.53; 1.60; 1.97; 3.48 score on a scale
N/A N=80 Lidocaine 5% Patch (Lidoderm) for the Prevention of Acute and Chest Pain Following Robotic Valve Surgery
Perioperative Chest Pain
Primary: Pain Disability Index Score (PDI) at Six Months Following Surgical Procedure — 26; 30; 12; 13 units on a scale — p=0.28
Phase 2 N=90 Pain Management in Children and Young Adults With Sickle Cell Disease
Sickle Cell Disease
Primary: Number of Participants With Successful Pain Interventions by Arm Between Presentation and 3 Hours Post Administration of Study Drug — 13; 17; 27; 25 Participants — p=0.227
N/A N=6 tDCS to Lower Neuropathic Pain and Fatigue in People With Multiple Sclerosis
Multiple Sclerosis
Primary: Neuropathic Pain Questionnaire (NPQ) Contains 12 Items. — 21.3; 10.3 Points
N/A N=220 Efficacy of Transversus Abdominis Plane Block Versus Local Injection of Pain Medication
Pain, Postoperative
Primary: Postoperative Pain on a Visual Analogue Pain Scale at One Hour Postoperatively — 4.04; 5.09; 4.4 units on a scale
Phase 4 N=27 Evaluation of Initiation Time on the Efficacy of Gabapentin in Treating Neuropathic Pain in SCI
Spinal Cord Injuries · Neuropathic Pain
Primary: Neuropathic Pain — 13.3; 15.6 units on a scale — p=0.67
N/A N=300 Treatment, Pain, and Opioids
Chronic Pain
Primary: Medical Record Review and Treatment Utilization Form — 19; 17 Participants — p=.6469
Phase 2 N=79 Mechanistic Study of Duloxetine in Breast Cancer Patients With Chronic Pain
Pain
Primary: Change in Patient-reported Worst Pain Between Baseline and 5 Weeks of Treatment With Duloxetine — 6.54; 0.25; 4.06 score on a scale
N/A N=42 Developing an Online Therapeutic Intervention for Chronic Pain in Veterans
Chronic Pain
Primary: System Usability Scale (SUS) — 79.6 score on a scale
Phase 4 N=258 Tapentadol Prolonged Release (PR) Versus Oxycodone/Naloxone Prolonged Release in Severe Chronic Low Back Pain With a Neuropathic Component.
Back Pain · Low Back Pain · Neuropathic Pain
Primary: Change in the Average Pain Intensity Score on an 11-point Numeric Rating Scale (NRS-3) — -3.7; -2.7 units on a scale
N/A N=328 Chronic Pain Skills Study
Chronic Pain
Primary: Change From Pre-Treatment in Average Pain Intensity on a 0-10 Numerical Rating Scale Immediately Following End of Treatment (Post-Treatment) — -.57; -.61; -.85 score on…
N/A N=20 Virtual Reality for Improving Pain and Distress in Patients With Advanced Stage Colorectal Cancer
Colorectal Cancer
Primary: Feasibility, Assessed by Examining Number of Participants Accrued — 20 Participants